Phase 3 Lung Cancer Metastatic Clinical Trials

2 recruitingPhase 3

What is a Phase 3 trial?

Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.

Showing 1–2 of 2 trials

Recruiting

Phase 3

Study Comparing the Standard Administration of IO Versus the Same IO Administered Each 3 Months in Patients in Response After 6 Months of Standard IO

Head and Neck CancerRenal Cell CarcinomaLung Cancer Metastatic

UNICANCER646 enrolled40 locationsNCT05078047

Recruiting

Phase 3

Armatinib Alone or in Combination With SRT for Brain Metastases EGFR-mutated Non-small Cell Lung Cancer

Non-small Cell Lung Cancer Metastatic

Shanghai Cancer Hospital, China300 enrolled1 locationNCT05800223